Our findings confirmed that NR4A2 haploinsufficiency was responsible for certain clinical features in patients and proposed the potential appearance of dystonia and/or parkinsonism related to NR4A2 which should be attached importance to in the follow-ups. This evidence concerns the gene NR4A2 and Parkinson disease.